Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy

The long-term effects of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy (CD19-CARTx) for B-cell malignancies on humoral immunity are unclear. We examined antiviral humoral immunity in 39 adults with B-cell malignancies who achieved durable complete remission without additional...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Hill, Joshua A., Krantz, Elizabeth M., Hay, Kevin A., Dasgupta, Sayan, Stevens-Ayers, Terry, Bender Ignacio, Rachel A., Bar, Merav, Maalouf, Joyce, Cherian, Sindhu, Chen, Xueyan, Pepper, Greg, Riddell, Stanley R., Maloney, David G., Boeckh, Michael J., Turtle, Cameron J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Immunobiology and Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6880890/
https://ncbi.nlm.nih.gov/pubmed/31743392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000717
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados